Compounds > voriconazole
Page last updated: 2024-08-25

voriconazole and Kahler Disease

voriconazole has been researched along with Kahler Disease in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's2 (22.22)29.6817
2010's5 (55.56)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Aronowitz, P; Kelley, KD; Thompson, GR1
Sebestyén, Z; Szabó, B; Szepesi, K1
Akyol, G; Atalay, A; Cakir, N; Kaynar, L; Koc, AN; Ulu-Kilic, A1
Burgess, M; Caradine, K; Kothari, A; Mohan, M; Rico, JC; Shalin, SC1
Abe, M; Fujii, S; Harada, T; Jinno, T; Kagawa, K; Matsumoto, T; Miki, H; Nakamura, S; Nakano, A; Ozaki, S; Takeuchi, K; Yata, K1
Hashimoto, N; Hattori, Y; Kato, J; Koda, Y; Mori, T; Okamoto, S; Sadahira, K; Shimizu, T; Tsukada, Y; Yamane, A; Yokoyama, K1
Howden, BP; Mijch, AM; Schwarer, AP; Slavin, MA1
Dinser, R; Grgic, A; Kim, YJ; Pfreundschuh, M; Schubert, J1
Audouin, AF; Breton, P; Germaud, P; Harousseau, JL; Milpied, N; Morin, O1

Reviews

1 review(s) available for voriconazole and Kahler Disease

ArticleYear
[Pharmaceutical applications of sulfobuthylether-beta-cyclodextrin].
    Acta pharmaceutica Hungarica, 2013, Volume: 83, Issue:2

    Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antiemetics; Antifungal Agents; Antipsychotic Agents; Aripiprazole; beta-Cyclodextrins; Chemistry, Pharmaceutical; Dosage Forms; Drug Stability; Humans; Hungary; Multiple Myeloma; Oligopeptides; Piperazines; Pyrimidines; Quinolones; Quinuclidines; Solubility; Thiazoles; Triazoles; Voriconazole

2013

Other Studies

8 other study(ies) available for voriconazole and Kahler Disease

ArticleYear
Mimicking Multiple Myeloma: Voriconazole-Induced Hyperfluorosis and Bone Lesions.
    Journal of general internal medicine, 2020, Volume: 35, Issue:3

    Topics: Bone Marrow; Humans; Multiple Myeloma; Voriconazole

2020
Pulmonary infection caused by Talaromyces purpurogenus in a patient with multiple myeloma.
    Le infezioni in medicina, 2016, Jun-01, Volume: 24, Issue:2

    Topics: Acinetobacter Infections; Aged; Antifungal Agents; Coinfection; Fatal Outcome; Female; Humans; Immunocompromised Host; Lung Diseases, Fungal; Multiple Myeloma; Opportunistic Infections; Plasmacytoma; Pulmonary Disease, Chronic Obstructive; Species Specificity; Spinal Neoplasms; Sputum; Talaromyces; Thoracic Vertebrae; Voriconazole

2016
Lasiodiplodia species fungal osteomyelitis in a multiple myeloma patient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:5

    Topics: Aged; Amphotericin B; Amputation, Surgical; Antifungal Agents; Antineoplastic Agents; Ascomycota; Biopsy; Blood Cell Count; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Multiple Myeloma; Osteomyelitis; Skin; Toes; Transplantation, Autologous; Treatment Refusal; Voriconazole

2016
[Multiple myeloma complicated with disseminated zygomycosis after bortezomib therapy].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2010, Volume: 51, Issue:8

    Topics: Acidosis; Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Echinocandins; Fatal Outcome; Humans; Lipopeptides; Male; Micafungin; Multiple Myeloma; Pyrazines; Pyrimidines; Triazoles; Tumor Lysis Syndrome; Voriconazole; Zygomycosis

2010
[Early onset of paralytic ileus caused by simultaneous administration of bortezomib and azole antifungals in multiple myeloma patients].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2012, Volume: 53, Issue:8

    Topics: Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Interactions; Drug Therapy, Combination; Humans; Intestinal Pseudo-Obstruction; Itraconazole; Middle Aged; Multiple Myeloma; Mycoses; Pyrazines; Pyrimidines; Triazoles; Voriconazole

2012
Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:2

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Middle Aged; Multiple Myeloma; Mycetoma; Naphthalenes; Opportunistic Infections; Pyrimidines; Risk Assessment; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole

2003
Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous stem cell
    European journal of haematology, 2005, Volume: 74, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Granulocytes; Humans; Leukocyte Transfusion; Lipopeptides; Magnetic Resonance Imaging; Male; Melphalan; Middle Aged; Multiple Myeloma; Necrosis; Peptides, Cyclic; Pyrimidines; Radiography; Stem Cell Transplantation; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole

2005
[Rare pulmonary mycoses in patients with hematologic diseases].
    Revue de pneumologie clinique, 1998, Volume: 54, Issue:5

    Topics: Acremonium; Adolescent; Adult; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Bone Marrow Transplantation; Female; Hematologic Neoplasms; Humans; Imidazoles; Leukemia, Myeloid, Acute; Lung; Lung Diseases, Fungal; Male; Middle Aged; Multiple Myeloma; Neutropenia; Penicillium; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudallescheria; Pyrimidines; Risk Factors; Triazoles; Voriconazole

1998